Diabetes & Vascular Disease Research

Scope & Guideline

Championing cutting-edge research in diabetes and vascular science.

Introduction

Explore the comprehensive scope of Diabetes & Vascular Disease Research through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Diabetes & Vascular Disease Research in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1479-1641
PublisherSAGE PUBLICATIONS LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2004 to 2024
AbbreviationDIABETES VASC DIS RE / Diabetes Vasc. Dis. Res.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND

Aims and Scopes

The journal 'Diabetes & Vascular Disease Research' focuses on the intersection of diabetes and vascular health, emphasizing research that explores the relationships between diabetes, cardiovascular diseases, and related complications. Its scope encompasses clinical studies, epidemiological research, and molecular investigations aimed at understanding the mechanisms underlying these conditions and improving patient outcomes.
  1. Diabetes and Cardiovascular Disease Interactions:
    Researching the impact of diabetes on cardiovascular health, including the prevalence of heart disease among diabetic patients and mechanisms of cardiovascular complications.
  2. Microvascular and Macrovascular Complications:
    Exploring the pathophysiology, risk factors, and treatment approaches for complications associated with diabetes, such as diabetic nephropathy, retinopathy, and peripheral artery disease.
  3. Innovative Therapeutic Approaches:
    Investigating new medications, treatment regimens, and interventions aimed at managing diabetes and its vascular complications, including pharmacological studies and real-world applications.
  4. Epidemiological Studies:
    Conducting population-based studies to assess the incidence, prevalence, and risk factors associated with diabetes and its complications across different demographics.
  5. Biomarkers and Molecular Mechanisms:
    Identifying biomarkers and understanding the molecular pathways involved in diabetes and vascular dysfunction to facilitate early diagnosis and targeted therapy.
Recent publications in 'Diabetes & Vascular Disease Research' reveal significant trends and emerging themes that are reshaping the understanding of diabetes and its vascular implications. These themes reflect advancements in technology, evolving treatment paradigms, and a deeper understanding of disease mechanisms.
  1. Role of Novel Therapeutics:
    An increasing focus on the efficacy of novel diabetes medications, particularly sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists, in reducing cardiovascular and renal risks associated with diabetes.
  2. Microvascular Complications and Inflammation:
    Emerging research is highlighting the role of inflammation in the development of microvascular complications, such as diabetic retinopathy and nephropathy, leading to new therapeutic targets.
  3. Integration of Technology in Diabetes Management:
    The use of continuous glucose monitoring systems and digital health technologies is trending, with research exploring their impact on glycemic control and patient outcomes.
  4. Psychosocial Factors in Diabetes Management:
    There is a growing recognition of the importance of psychological and social factors in diabetes management, with studies investigating how these factors influence disease progression and treatment adherence.
  5. Longitudinal and Cohort Studies:
    A trend towards conducting longitudinal studies that track diabetes progression and its vascular complications over time, providing insights into long-term outcomes and risk factors.

Declining or Waning

While certain areas of research maintain a robust presence in the journal, others appear to be declining in frequency or relevance. This decline may suggest shifts in research priorities or advancements in understanding that make some previously emphasized topics less prominent.
  1. Historical Cardiovascular Risk Factors:
    Research focusing on traditional cardiovascular risk factors in isolation, such as cholesterol levels or hypertension, appears to be waning as studies increasingly emphasize the interconnectivity between diabetes and broader health outcomes.
  2. Basic Science Approaches without Clinical Applications:
    There seems to be a decrease in purely basic science studies that do not directly translate to clinical practice or patient outcomes, as the journal shifts towards more translational research that impacts patient care.
  3. Single-Factor Studies:
    Studies that examine the effects of diabetes on vascular health in isolation without considering the multifactorial nature of these diseases are becoming less common, reflecting a trend towards a more holistic approach in research.

Similar Journals

EJVES Vascular Forum

Driving Innovation in Cardiovascular Health
Publisher: ELSEVIERISSN: 2666-688XFrequency:

EJVES Vascular Forum, published by Elsevier, is a premier open access journal focusing on the interdisciplinary field of vascular surgery and cardiovascular medicine. Since its inception in 2001, the journal has provided a vital platform for the dissemination of high-quality research and innovative clinical practices, addressing critical issues in vascular health. With an ISSN of 2666-688X, it has gained recognition within its community, attaining a Q3 quartile ranking in both cardiology and surgery categories as of 2023, and showcasing its relevance and impact within the medical research landscape. Situated in the United Kingdom and accessible globally, the EJVES Vascular Forum invites contributions that foster collaboration and enhance knowledge in vascular surgery, making it an essential resource for researchers, professionals, and students alike. The journal's ranking within Scopus highlights its position among peers, adding further credence to its objectives of advancing science and improving patient care in the cardiovascular realm. By publishing rigorously peer-reviewed articles, the journal aims to be the go-to source of information and innovation for those dedicated to the progress of vascular health.

Vascular

Elevating the discourse on cardiovascular innovations.
Publisher: SAGE PUBLICATIONS LTDISSN: 1708-5381Frequency: 6 issues/year

Vascular is a premier academic journal published by SAGE Publications Ltd, focusing on a wide range of disciplines within the fields of cardiology, cardiovascular medicine, surgery, and radiology. Established in 1993 and continuing through 2024, this journal serves as an essential resource for researchers and professionals seeking to advance their understanding of vascular health and disease. With an impressive categorization in the Q3 quartile for cardiology and cardiovascular medicine, and Q2 quartile for surgery, Vascular has established itself as a reputable platform for disseminating cutting-edge research and innovative clinical practices. The journal's positioning in various Scopus Ranks reflects its relevance and contribution to advancing these critical medical fields, making it an indispensable tool for students, clinicians, and researchers alike. For those interested in keeping abreast of the latest developments, Vascular offers a rich repository of articles that contribute significantly to the global discourse on vascular diseases.

Diabetology & Metabolic Syndrome

Connecting researchers to transform metabolic health.
Publisher: BMCISSN: Frequency: 1 issue/year

Diabetology & Metabolic Syndrome is a premier open-access journal published by BMC, dedicated to advancing the field of endocrinology, diabetes, and metabolic syndrome. Since its inception in 2009, the journal has established itself as a leading platform for original research, reviews, and clinical studies, offering comprehensive insights into the complexities of metabolic diseases. With an impressive ranking in the 2023 category quartiles as Q1 in both Endocrinology, Diabetes and Metabolism, and Internal Medicine, it stands among the top-tier journals in its field. Researchers will appreciate its strong emphasis on disseminating critical findings that influence clinical practices and public health policies. Accessible to a global audience, Diabetology & Metabolic Syndrome's commitment to open access enables the distribution of high-quality research without barriers, fostering an inclusive environment for knowledge sharing. With a strategic focus on the intersection of diabetes management and metabolic disorders, this journal is essential for professionals seeking to stay abreast of the latest developments and contribute to a vital area of healthcare.

CURRENT DIABETES REVIEWS

Fostering Collaboration in Diabetes Research
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-3998Frequency: 9 issues/year

CURRENT DIABETES REVIEWS is a leading academic journal published by Bentham Science Publishers Ltd, dedicated to disseminating high-quality reviews and cutting-edge insights in the field of Endocrinology, Diabetes and Metabolism. Established in 1996 and actively publishing from 2005 to 2024, this journal holds a prestigious position within the academic community, evidenced by its Q2 ranking in both relevant categories for 2023 and its impactful presence in Scopus, where it ranks #83 out of 244 in Endocrinology and Diabetes and Metabolism. Despite being a subscription-based journal, it provides researchers, healthcare professionals, and students with valuable contributions that significantly advance the understanding of diabetes and related metabolic disorders. With a commitment to promoting interdisciplinary collaboration and innovation, CURRENT DIABETES REVIEWS serves as an essential resource for those seeking to stay abreast of the latest developments in diabetes research and therapies.

Current Vascular Pharmacology

Elevating Standards in Vascular Medicine and Drug Discovery
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1570-1611Frequency: 6 issues/year

Current Vascular Pharmacology is a premier academic journal published by Bentham Science Publications Ltd, focusing on the intersection of pharmacology and cardiovascular medicine. With an impact factor that reflects its significance in the field, this journal ranks in the Q1 category for both Pharmacology and Cardiology, showcasing its dedication to high-quality research. Its Scopus ranks place it in the top percentile of its categories, highlighting its influence among scholars and practitioners alike. Issued since 2003 and continuing through 2024, Current Vascular Pharmacology aims to disseminate cutting-edge findings and foster knowledge exchange among researchers, professionals, and students engaged in cardiovascular pharmacology. Despite being a subscription-based journal, it remains a vital resource for those seeking the latest advancements in drug development and therapeutic interventions for vascular diseases. Located in the United Arab Emirates, the journal serves as an essential platform for global discourse on vascular health.

International Journal of Angiology

Exploring innovative insights in angiology and cardiology.
Publisher: THIEME MEDICAL PUBL INCISSN: 1061-1711Frequency: 4 issues/year

Welcome to the International Journal of Angiology, a distinguished publication dedicated to advancing the field of cardiology and cardiovascular medicine. Published by THIEME MEDICAL PUBL INC, this journal plays a crucial role in disseminating innovative research and clinical insights from 1992 through 2024, serving as a vital resource for researchers, healthcare professionals, and students alike. With an ISSN of 1061-1711 and an E-ISSN of 1615-5939, the journal currently holds a respectable Q4 ranking in the cardiology field, reflecting its commitment to quality and relevance. Although it operates under a traditional access model, the journal ensures that critical research findings are shared with a broad audience, fostering collaboration and knowledge exchange. By exploring current trends, diagnostic techniques, and treatment modalities in angiology, the International Journal of Angiology remains an essential platform for those dedicated to improving cardiovascular health around the globe.

Vascular Health and Risk Management

Connecting experts to tackle vascular health challenges.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1176-6344Frequency: 1 issue/year

Vascular Health and Risk Management is a leading peer-reviewed journal published by DOVE MEDICAL PRESS LTD, focusing on the critical areas of cardiology, endocrinology, and public health. With an impact factor that reflects its significance within the scientific community, this Open Access journal, established in 2005, has been committed to enhancing knowledge on the interplay between vascular health and various risk factors affecting patient outcomes. The journal is proudly based in New Zealand and is indexed across multiple categories, maintaining a prominent Q2 ranking in cardiology, endocrinology, diabetes, and several other medical disciplines as of 2023. By providing a platform for innovative research and comprehensive reviews, Vascular Health and Risk Management seeks to foster collaboration among healthcare professionals, enhance clinical practices, and ultimately improve patient care through rigorous scientific inquiry and disseminated knowledge. Researchers, professionals, and students will find invaluable insights that inform their work and advance the understanding of vascular-related health issues.

ANGIOLOGY

Exploring the Future of Cardiovascular Care
Publisher: SAGE PUBLICATIONS INCISSN: 0003-3197Frequency: 10 issues/year

ANGIOLOGY is a leading journal dedicated to the field of cardiology and cardiovascular medicine, published by SAGE Publications Inc. With a distinguished history dating back to 1950, this journal serves as an essential platform for the dissemination of cutting-edge research, innovative clinical practices, and emerging trends in cardiovascular health. Holding a respected Q2 ranking in the 2023 Scopus category for Cardiology and Cardiovascular Medicine, and positioned within the 74th percentile of its field, ANGIOLOGY is an invaluable resource for researchers, healthcare professionals, and students alike. While currently not an open-access journal, it offers subscription options to access comprehensive articles that aim to advance knowledge and improve patient care across various cardiovascular disciplines. The journal's commitment to fostering dialogue and sharing groundbreaking findings underscores its importance in the ongoing pursuit of cardiovascular excellence.

Cardiovascular Diabetology

Connecting Cardiology and Endocrinology for Healthier Futures
Publisher: BMCISSN: Frequency: 1 issue/year

Cardiovascular Diabetology is a prestigious open-access journal published by BMC, focusing on the intersecting fields of cardiology, endocrinology, diabetes, and internal medicine. Since its inception in 2002, this journal has established itself as a vital resource for researchers, clinicians, and academics dedicated to advancing knowledge in these areas. With an impressive impact factor reflected in its Q1 rankings for the year 2023 across its respective categories, including a ranking of 22nd in Cardiology and Cardiovascular Medicine and notably 15th in Internal Medicine, it positions itself at the forefront of scholarly communication. The journal encourages the dissemination and sharing of groundbreaking research, providing open access to foster engagement and collaboration among professionals globally. As it converges from 2002 to 2024, Cardiovascular Diabetology continues to be a pivotal platform for innovative studies, reviews, and critical insights that significantly impact clinical practices and medical education in the evolving landscape of cardiovascular health and diabetes management.

VASCULAR MEDICINE

Elevating the standards of vascular health through rigorous scholarship.
Publisher: SAGE PUBLICATIONS LTDISSN: 1358-863XFrequency: 6 issues/year

Vascular Medicine is a premier academic journal for researchers and practitioners in the field of cardiovascular health, published by SAGE Publications Ltd. With an ISSN of 1358-863X and E-ISSN 1477-0377, this esteemed journal has been at the forefront of publishing quality research since its inception in 1992, with convergence extending to 2024. Ranked in the Q2 category for both Cardiology and Cardiovascular Medicine as well as for miscellaneous Medicine in 2023, it is recognized for its significant contributions to advancing knowledge and clinical practice within these domains. Its Scopus ranking situates it at #91 out of 387 in the field, reflecting its high impact and the relevance of its published research, which is crucial for addressing the challenges in vascular health today. Although it is not an open-access journal, Vascular Medicine remains dedicated to disseminating vital findings that bridge the gap between research and clinical application, making it an essential resource for medical researchers, healthcare professionals, and students alike.